Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Subcutaneous injection of immune proteins is well tolerated and safe, and is clinically suitable for all patients. Subcutaneous immunoglobulin is superior to intravenous immunoglobulin because it does not require intravenous access and reduces the need for prodrug therapy with glucocorticoids and antihistamines. Due to the reduction of global market participants and the time interval between plasma collection and product launch, the production of subcutaneous immunoglobulin becomes cumbersome and time-consuming, and if not managed properly, it will hinder the subcutaneous immunoglobulin market during the forecast period.
In July 2019, Grifols announced that Xembify has been approved by the US Food and Drug Administration. This is a new 20% subcutaneous immunoglobulin product for the treatment of patients with idiopathic immunodeficiency 2 years and older.
The increase in the incidence of autoimmune diseases will help drive the growth of this market during the forecast period. The deepening of the aging population has led to an increase in the infectivity of the elderly population, and the prevalence of several diseases such as cancer, diabetes and neurological diseases is rising, which has driven the global demand for subcutaneous immunoglobulin market.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Subcutaneous Immunoglobulins market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Subcutaneous Immunoglobulins market. Detailed analysis of key players, along with key growth strategies adopted by Subcutaneous Immunoglobulins industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
CSL
Grifols
Shire (Baxalta)
By Type:
10% Purity
20% Purity
By End-User:
Primary Immunodeficiency
Secondary Immunodeficiency
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Subcutaneous Immunoglobulins Market
-
1.3 Market Segment by Type
-
1.3.1 China Subcutaneous Immunoglobulins Market Size and Growth Rate of 10% Purity from 2016 to 2027
-
1.3.2 China Subcutaneous Immunoglobulins Market Size and Growth Rate of 20% Purity from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Subcutaneous Immunoglobulins Market Size and Growth Rate of Primary Immunodeficiency from 2016 to 2027
-
1.4.2 China Subcutaneous Immunoglobulins Market Size and Growth Rate of Secondary Immunodeficiency from 2016 to 2027
-
1.4.3 China Subcutaneous Immunoglobulins Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Subcutaneous Immunoglobulins Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Subcutaneous Immunoglobulins by Major Types
-
3.4.1 Market Size and Growth Rate of 10% Purity
-
3.4.2 Market Size and Growth Rate of 20% Purity
4 Segmentation of Subcutaneous Immunoglobulins Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Subcutaneous Immunoglobulins by Major End-Users
-
4.4.1 Market Size and Growth Rate of Subcutaneous Immunoglobulins in Primary Immunodeficiency
-
4.4.2 Market Size and Growth Rate of Subcutaneous Immunoglobulins in Secondary Immunodeficiency
-
4.4.3 Market Size and Growth Rate of Subcutaneous Immunoglobulins in Others
5 Market Analysis by Regions
-
5.1 China Subcutaneous Immunoglobulins Production Analysis by Regions
-
5.2 China Subcutaneous Immunoglobulins Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Subcutaneous Immunoglobulins Landscape Analysis
-
6.1 North China Subcutaneous Immunoglobulins Landscape Analysis by Major Types
-
6.2 North China Subcutaneous Immunoglobulins Landscape Analysis by Major End-Users
7 Central China Subcutaneous Immunoglobulins Landscape Analysis
-
7.1 Central China Subcutaneous Immunoglobulins Landscape Analysis by Major Types
-
7.2 Central China Subcutaneous Immunoglobulins Landscape Analysis by Major End-Users
8 South China Subcutaneous Immunoglobulins Landscape Analysis
-
8.1 South China Subcutaneous Immunoglobulins Landscape Analysis by Major Types
-
8.2 South China Subcutaneous Immunoglobulins Landscape Analysis by Major End-Users
9 East China Subcutaneous Immunoglobulins Landscape Analysis
-
9.1 East China Subcutaneous Immunoglobulins Landscape Analysis by Major Types
-
9.2 East China Subcutaneous Immunoglobulins Landscape Analysis by Major End-Users
10 Northeast China Subcutaneous Immunoglobulins Landscape Analysis
-
10.1 Northeast China Subcutaneous Immunoglobulins Landscape Analysis by Major Types
-
10.2 Northeast China Subcutaneous Immunoglobulins Landscape Analysis by Major End-Users
11 Southwest China Subcutaneous Immunoglobulins Landscape Analysis
-
11.1 Southwest China Subcutaneous Immunoglobulins Landscape Analysis by Major Types
-
11.2 Southwest China Subcutaneous Immunoglobulins Landscape Analysis by Major End-Users
12 Northwest China Subcutaneous Immunoglobulins Landscape Analysis
-
12.1 Northwest China Subcutaneous Immunoglobulins Landscape Analysis by Major Types
-
12.2 Northwest China Subcutaneous Immunoglobulins Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 CSL
-
13.1.1 CSL Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Grifols
-
13.2.1 Grifols Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Shire (Baxalta)
-
13.3.1 Shire (Baxalta) Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Subcutaneous Immunoglobulins Market Size and Growth Rate of 10% Purity from 2016 to 2027
-
Figure China Subcutaneous Immunoglobulins Market Size and Growth Rate of 20% Purity from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Subcutaneous Immunoglobulins Market Size and Growth Rate of Primary Immunodeficiency from 2016 to 2027
-
Figure China Subcutaneous Immunoglobulins Market Size and Growth Rate of Secondary Immunodeficiency from 2016 to 2027
-
Figure China Subcutaneous Immunoglobulins Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Subcutaneous Immunoglobulins Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Subcutaneous Immunoglobulins
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Subcutaneous Immunoglobulins by Different Types from 2016 to 2027
-
Table Consumption Share of Subcutaneous Immunoglobulins by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of 10% Purity
-
Figure Market Size and Growth Rate of 20% Purity
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Subcutaneous Immunoglobulins by Different End-Users from 2016 to 2027
-
Table Consumption Share of Subcutaneous Immunoglobulins by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Primary Immunodeficiency
-
Figure Market Size and Growth Rate of Secondary Immunodeficiency
-
Figure Market Size and Growth Rate of Others
-
Table China Subcutaneous Immunoglobulins Production by Regions
-
Table China Subcutaneous Immunoglobulins Production Share by Regions
-
Figure China Subcutaneous Immunoglobulins Production Share by Regions in 2016
-
Figure China Subcutaneous Immunoglobulins Production Share by Regions in 2021
-
Figure China Subcutaneous Immunoglobulins Production Share by Regions in 2027
-
Table China Subcutaneous Immunoglobulins Consumption by Regions
-
Table China Subcutaneous Immunoglobulins Consumption Share by Regions
-
Figure China Subcutaneous Immunoglobulins Consumption Share by Regions in 2016
-
Figure China Subcutaneous Immunoglobulins Consumption Share by Regions in 2021
-
Figure China Subcutaneous Immunoglobulins Consumption Share by Regions in 2027
-
Table North China Subcutaneous Immunoglobulins Consumption by Types from 2016 to 2027
-
Table North China Subcutaneous Immunoglobulins Consumption Share by Types from 2016 to 2027
-
Figure North China Subcutaneous Immunoglobulins Consumption Share by Types in 2016
-
Figure North China Subcutaneous Immunoglobulins Consumption Share by Types in 2021
-
Figure North China Subcutaneous Immunoglobulins Consumption Share by Types in 2027
-
Table North China Subcutaneous Immunoglobulins Consumption by End-Users from 2016 to 2027
-
Table North China Subcutaneous Immunoglobulins Consumption Share by End-Users from 2016 to 2027
-
Figure North China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2016
-
Figure North China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2021
-
Figure North China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2027
-
Table Central China Subcutaneous Immunoglobulins Consumption by Types from 2016 to 2027
-
Table Central China Subcutaneous Immunoglobulins Consumption Share by Types from 2016 to 2027
-
Figure Central China Subcutaneous Immunoglobulins Consumption Share by Types in 2016
-
Figure Central China Subcutaneous Immunoglobulins Consumption Share by Types in 2021
-
Figure Central China Subcutaneous Immunoglobulins Consumption Share by Types in 2027
-
Table Central China Subcutaneous Immunoglobulins Consumption by End-Users from 2016 to 2027
-
Table Central China Subcutaneous Immunoglobulins Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2016
-
Figure Central China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2021
-
Figure Central China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2027
-
Table South China Subcutaneous Immunoglobulins Consumption by Types from 2016 to 2027
-
Table South China Subcutaneous Immunoglobulins Consumption Share by Types from 2016 to 2027
-
Figure South China Subcutaneous Immunoglobulins Consumption Share by Types in 2016
-
Figure South China Subcutaneous Immunoglobulins Consumption Share by Types in 2021
-
Figure South China Subcutaneous Immunoglobulins Consumption Share by Types in 2027
-
Table South China Subcutaneous Immunoglobulins Consumption by End-Users from 2016 to 2027
-
Table South China Subcutaneous Immunoglobulins Consumption Share by End-Users from 2016 to 2027
-
Figure South China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2016
-
Figure South China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2021
-
Figure South China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2027
-
Table East China Subcutaneous Immunoglobulins Consumption by Types from 2016 to 2027
-
Table East China Subcutaneous Immunoglobulins Consumption Share by Types from 2016 to 2027
-
Figure East China Subcutaneous Immunoglobulins Consumption Share by Types in 2016
-
Figure East China Subcutaneous Immunoglobulins Consumption Share by Types in 2021
-
Figure East China Subcutaneous Immunoglobulins Consumption Share by Types in 2027
-
Table East China Subcutaneous Immunoglobulins Consumption by End-Users from 2016 to 2027
-
Table East China Subcutaneous Immunoglobulins Consumption Share by End-Users from 2016 to 2027
-
Figure East China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2016
-
Figure East China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2021
-
Figure East China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2027
-
Table Northeast China Subcutaneous Immunoglobulins Consumption by Types from 2016 to 2027
-
Table Northeast China Subcutaneous Immunoglobulins Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Subcutaneous Immunoglobulins Consumption Share by Types in 2016
-
Figure Northeast China Subcutaneous Immunoglobulins Consumption Share by Types in 2021
-
Figure Northeast China Subcutaneous Immunoglobulins Consumption Share by Types in 2027
-
Table Northeast China Subcutaneous Immunoglobulins Consumption by End-Users from 2016 to 2027
-
Table Northeast China Subcutaneous Immunoglobulins Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2016
-
Figure Northeast China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2021
-
Figure Northeast China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2027
-
Table Southwest China Subcutaneous Immunoglobulins Consumption by Types from 2016 to 2027
-
Table Southwest China Subcutaneous Immunoglobulins Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Subcutaneous Immunoglobulins Consumption Share by Types in 2016
-
Figure Southwest China Subcutaneous Immunoglobulins Consumption Share by Types in 2021
-
Figure Southwest China Subcutaneous Immunoglobulins Consumption Share by Types in 2027
-
Table Southwest China Subcutaneous Immunoglobulins Consumption by End-Users from 2016 to 2027
-
Table Southwest China Subcutaneous Immunoglobulins Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2016
-
Figure Southwest China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2021
-
Figure Southwest China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2027
-
Table Northwest China Subcutaneous Immunoglobulins Consumption by Types from 2016 to 2027
-
Table Northwest China Subcutaneous Immunoglobulins Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Subcutaneous Immunoglobulins Consumption Share by Types in 2016
-
Figure Northwest China Subcutaneous Immunoglobulins Consumption Share by Types in 2021
-
Figure Northwest China Subcutaneous Immunoglobulins Consumption Share by Types in 2027
-
Table Northwest China Subcutaneous Immunoglobulins Consumption by End-Users from 2016 to 2027
-
Table Northwest China Subcutaneous Immunoglobulins Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2016
-
Figure Northwest China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2021
-
Figure Northwest China Subcutaneous Immunoglobulins Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of CSL
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL
-
Figure Sales and Growth Rate Analysis of CSL
-
Figure Revenue and Market Share Analysis of CSL
-
Table Product and Service Introduction of CSL
-
Table Company Profile and Development Status of Grifols
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols
-
Figure Sales and Growth Rate Analysis of Grifols
-
Figure Revenue and Market Share Analysis of Grifols
-
Table Product and Service Introduction of Grifols
-
Table Company Profile and Development Status of Shire (Baxalta)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire (Baxalta)
-
Figure Sales and Growth Rate Analysis of Shire (Baxalta)
-
Figure Revenue and Market Share Analysis of Shire (Baxalta)
-
Table Product and Service Introduction of Shire (Baxalta)
-
